Comparative evaluation of local control strategies in localized Ewing sarcoma of bone: A report from the Children's Oncology Group

Cancer

Volumn 121, Issue 3, 2015, Pages 467-475

  DuBois, Steven G ^a   Krailo, Mark D ^b   Gebhardt, Mark C ^c   Donaldson, Sarah S ^d   Marcus, Karen J ^c   Dormans, John ^e   Shamberger, Robert C ^c   Sailer, Scott ^f   Nicholas, Richard W ^g   Healey, John H ^h   Tarbell, Nancy J ^c   Randall, R Lor ⁱ   Devidas, Meenakshi ^j   Meyer, James S ^e   Granowetter, Linda ^k   Womer, Richard B ^e   Bernstein, Mark ^l   Marina, Neyssa ^d   Grier, Holcombe E ^c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF PENNSYLVANIA   (United States)

^f Wake Radiation Oncology   (United States)

^g UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^h MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

ⁱ UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^j Children's Oncology Group Statistics and Data Center   (United States)

^k NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^l IWK HEALTH CENTRE   (Canada)

more..

Author keywords

Ewing sarcoma; Local control; Propensity score; Radiation; Surgery

Indexed keywords

ANTINEOPLASTIC AGENT;

ADOLESCENT; ADULT; AGE; ARTICLE; CANCER CONTROL; CANCER RADIOTHERAPY; CHILD; CONTROLLED STUDY; EVENT FREE SURVIVAL; EWING SARCOMA; FEMALE; HUMAN; INFANT; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; ORTHOPEDIC SURGERY; OVERALL SURVIVAL; TREATMENT FAILURE; BONE NEOPLASMS; COHORT ANALYSIS; MULTIVARIATE ANALYSIS; RANDOMIZED CONTROLLED TRIAL (TOPIC); SARCOMA, EWING;

ADOLESCENT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BONE NEOPLASMS; CHILD; COHORT STUDIES; FEMALE; HUMANS; MALE; MULTIVARIATE ANALYSIS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SARCOMA, EWING;

EID: 84921524920     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.29065     Document Type: Article

References (19)

1. Donaldson SS. Ewing sarcoma: radiation dose and target volume. Pediatr Blood Cancer. 2004;42:471-476.
2. Hosalkar HS, Dormans JP. Limb sparing surgery for pediatric musculoskeletal tumors. Pediatr Blood Cancer. 2004;42:295-310.
3. Rubin DB. Estimating causal effects from large data sets using propensity scores. Ann Intern Med. 1997;127:757-763.
4. Grier HE, Krailo MD, Tarbell NJ, et al. Addition of ifosfamide and etoposide to standard chemotherapy for Ewing's sarcoma and primitive neuroectodermal tumor of bone. N Engl J Med. 2003;348:694-701.
5. Granowetter L, Womer R, Devidas M, et al. Dose-intensified compared with standard chemotherapy for nonmetastatic Ewing sarcoma family of tumors: a Children's Oncology Group Study. J Clin Oncol. 2009;27:2536-2541.
6. Womer RB, West DC, Krailo MD, et al. Randomized controlled trial of interval-compressed chemotherapy for the treatment of localized Ewing sarcoma: a report from the Children's Oncology Group. J Clin Oncol. 2012;30:4148-4154.
7. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc. 1958;53:457-481.
8. Fine J, Gray R. A Proportional hazards model for the subdistribution of a competing risk. J Am Stat Assoc. 1999;94:496-509.
9. Bacci G, Ferrari S, Bertoni F, et al. Prognostic factors in nonmetastatic Ewing's sarcoma of bone treated with adjuvant chemotherapy: analysis of 359 patients at the Istituto Ortopedico Rizzoli. J Clin Oncol. 2000;18:4-11.
10. Bacci G, Forni C, Longhi A, et al. Long-term outcome for patients with non-metastatic Ewing's sarcoma treated with adjuvant and neoadjuvant chemotherapies. 402 patients treated at Rizzoli between 1972 and 1992. Eur J Cancer. 2004;40:73-83.
11. Bacci G, Longhi A, Briccoli A, Bertoni F, Versari M, Picci P. The role of surgical margins in treatment of Ewing's sarcoma family tumors: experience of a single institution with 512 patients treated with adjuvant and neoadjuvant chemotherapy. Int J Radiat Oncol Biol Phys. 2006;65:766-772.
12. Shankar AG, Pinkerton CR, Atra A, et al. Local therapy and other factors influencing site of relapse in patients with localised Ewing's sarcoma. United Kingdom Children's Cancer Study Group (UKCCSG). Eur J Cancer. 1999;35:1698-1704.
13. Dunst J, Sauer R, Burgers JM, et al. Radiation therapy as local treatment in Ewing's sarcoma. Results of the Cooperative Ewing's Sarcoma Studies CESS 81 and CESS 86. Cancer. 1991;67:2818-2825.
14. Ahrens S, Hoffmann C, Jabar S, et al. Evaluation of prognostic factors in a tumor volume-adapted treatment strategy for localized Ewing sarcoma of bone: the CESS 86 experience. Cooperative Ewing Sarcoma Study. Med Pediatr Oncol. 1999;32:186-195.
15. Dunst J, Jurgens H, Sauer R, et al. Radiation therapy in Ewing's sarcoma: an update of the CESS 86 trial. Int J Radiat Oncol Biol Phys. 1995;32:919-930.
16. Ozaki T, Hillmann A, Hoffmann C, et al. Significance of surgical margin on the prognosis of patients with Ewing's sarcoma. A report from the Cooperative Ewing's Sarcoma Study. Cancer. 1996;78:892-900.
17. Schuck A, Ahrens S, Paulussen M, et al. Local therapy in localized Ewing tumors: results of 1058 patients treated in the CESS 81, CESS 86, and EICESS 92 trials. Int J Radiat Oncol Biol Phys. 2003;55:168-177.
18. Yock TI, Krailo M, Fryer CJ, et al. Local control in pelvic Ewing sarcoma: analysis from INT-0091-a report from the Children's Oncology Group. J Clin Oncol. 2006;24:3838-3843.
19. Goldsby R, Burke C, Nagarajan R, et al. Second solid malignancies among children, adolescents, and young adults diagnosed with malignant bone tumors after 1976: follow-up of a Children's Oncology Group cohort. Cancer. 2008;113:2597-2604.